EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Linking Antibodies Against Apolipoprotein A-1 to Metabolic Dysfunction-Associated Steatohepatitis in Mice

Sabrina Pagano, Emmanuel Somm, Catherine Juillard, Nicolas Liaudet iD, Frédérique Ino, Johan Ferrari, Vincent Braunersreuther, François R Jornayvaz iD, Nicolas Vuilleumier

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252211875 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Sabrina Pagano und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Laboratory Medicine, Diagnostic Department, Geneva University Hospitals, 1211 Geneva, Switzerland. Hauptthemen laut MEDLINE: Apolipoprotein A-I, Mice, Inbred C57BL, Fatty Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss Science national, Fondation Ernst et Lucie Schmidheiny, Ernst et Lucie Schmidheiny.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated fatty liver disease (MASLD) is a common liver and health issue associated with heightened cardiovascular disease (CVD) risk, with Cytokeratin 18 (CK-18) as a marker of liver injury across the MASLD to cirrhosis spectrum. Autoantibodies against apolipoprotein A-1 (AAA-1s) predict increased CVD risk, promoting atherosclerosis and liver steatosis in apoE−/− mice, though their impact on liver inflammation and fibrosis remains unclear. This study examined AAA-1s’ impact on low-grade inflammation, liver steatosis, and fibrosis using a MASLD mouse model exposed to AAA-1s passive immunization (PI). Ten-week-old male C57BL/6J mice under a high-fat diet underwent PI with AAA-1s or control antibodies for ten days. Compared to controls, AAA-1-immunized mice showed higher plasma CK-18 (5.3 vs. 2.1 pg/mL, p = 0.031), IL-6 (13 vs. 6.9 pg/mL, p = 0.035), IL-10 (27.3 vs. 9.8 pg/mL, p = 0.007), TNF-α (32.1 vs. 24.2 pg/mL, p = 0.032), and liver steatosis (93.4% vs. 73.8%, p = 0.007). Transcriptomic analyses revealed hepatic upregulation of pro-fibrotic mRNAs in AAA-1-recipient mice, though histological changes were absent. In conclusion, short-term AAA-1 PI exacerbated liver steatosis, inflammation, and pro-fibrotic gene expression, suggesting that AAA-1s may play a role in MASLD progression. Further research with prolonged AAA-1 exposure is warranted to clarify their potential role in liver fibrosis and associated complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Apolipoprotein A-IMice, Inbred C57BLFatty LiverAnimalsMiceMaleAutoantibodiesDisease Models, AnimalDiet, High-FatLiverKeratin-18

Stichwörter der Autor:innen

CDAHFD mouseCytokeratin 18MASHMASLDanti-apolipoprotein A1 antibodiesinflammation

Substanzen

Apolipoprotein A-IAutoantibodiesKeratin-18

Autor:innen und Institutionen

  • Division of Laboratory Medicine, Diagnostic Department, Geneva University Hospitals, 1211 Geneva, Switzerland.
  • Department of Medicine, Medical Faculty, Geneva University, 1211 Geneva, Switzerland.
  • Service of Endocrinology, Diabetes, Nutrition and Therapeutic Patient Education, Department of Internal Medicine, Geneva University Hospitals, 1211 Geneva, Switzerland.
  • Department of Cell Physiology and Metabolism, University of Geneva, 1211 Geneva, Switzerland.
  • Diabetes Center, the Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.
  • Bioimaging Core Facility, Medical Faculty, University of Geneva, 1211 Geneva, Switzerland.

ORCID-Profile: Nicolas Liaudet, François R Jornayvaz

Förderung

  • Swiss Science national
  • Fondation Ernst et Lucie Schmidheiny
  • Ernst et Lucie Schmidheiny
  • Swiss National Foundation

Zitieren

APA

Pagano, S., Somm, E., Juillard, C., Liaudet, N., Ino, F., Ferrari, J., Braunersreuther, V., Jornayvaz, F. R., & Vuilleumier, N. (2024). Linking Antibodies Against Apolipoprotein A-1 to Metabolic Dysfunction-Associated Steatohepatitis in Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252211875

Vancouver

Pagano S, Somm E, Juillard C, Liaudet N, Ino F, Ferrari J, et al. Linking Antibodies Against Apolipoprotein A-1 to Metabolic Dysfunction-Associated Steatohepatitis in Mice. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252211875

BibTeX
@article{Pagano2024,
  author = {Pagano, Sabrina and Somm, Emmanuel and Juillard, Catherine and Liaudet, Nicolas and Ino, Frédérique and Ferrari, Johan and Braunersreuther, Vincent and Jornayvaz, François R and Vuilleumier, Nicolas},
  title = {Linking Antibodies Against Apolipoprotein A-1 to Metabolic Dysfunction-Associated Steatohepatitis in Mice},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252211875}
}
Kostenlos starten →